Hepatogastroenterology Unit, 2nd Department of Internal Medicine - Propaedeutic, Attikon University General Hospital, Medical School, Athens University, Chaidari, Greece.
Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):203-15. doi: 10.1016/j.bpg.2010.02.004.
It is expected that the percentage of people >60 years of age will be 22% worldwide by the year 2050. Multi-morbidity and poly-pharmacy are common in individuals during old age, while adverse drug reactions are at least twice as common in the elderly compared to younger adults. Publications related to drug side effects are rather rare in this age group since most clinical trials exclude patients >75-80 years of age. Gastrointestinal adverse drug reactions studied in the elderly include non-steroidal anti-inflammatory drugs (NSAIDs) and anticoagulant-induced gastrointestinal tract mucosal injuries. Malabsorption, diarrhoea and constipation are common side effects of laxatives, antibiotics, anticholinergics and calcium channel blockers. Drug (amoxycilin/clavulanic acid, isoniazide, nitrofurantoin, diclifenac and methotrexate)-induced hepatotoxicity in the elderly is four times more common than in younger adults and may simulate almost all known liver disorders. Further clinical studies are needed to investigate gastrointestinal and hepatic side effects of drugs in elderly patients.
预计到 2050 年,全球 60 岁以上人口的比例将达到 22%。老年人中多病共存和多药并用很常见,而与年轻人相比,老年人的药物不良反应至少多出两倍。由于大多数临床试验排除了>75-80 岁的患者,因此该年龄段与药物副作用相关的出版物相当罕见。在老年人中研究的胃肠道药物不良反应包括非甾体抗炎药(NSAIDs)和抗凝剂引起的胃肠道黏膜损伤。吸收不良、腹泻和便秘是泻药、抗生素、抗胆碱能药物和钙通道阻滞剂的常见副作用。老年人的药物(阿莫西林/克拉维酸、异烟肼、呋喃妥因、双氯芬酸和甲氨蝶呤)诱导的肝毒性比年轻人常见四倍,并且可能模拟几乎所有已知的肝脏疾病。需要进一步的临床研究来调查老年患者的胃肠道和肝脏药物副作用。